As new drugs are emerging every day, it is very\nimportant to ensure that the patients get right and effective treatment. One\nsuch step can be taken from Real World Evidence (RWE). In simple words, Real\nWorld Evidence means data and information collected outside of a clinical\ntrial. This data can be electronic medical records, medical charts or other\nmedical claims to assess patient outcomes.<\/p>\n\n\n\n
It is made sure that the patient’s identity is removed from the previous data to maintain the patient’s privacy. However, today\u2019s real-world evidence data is acting as an obstacle in the pharmaceutical industry as it is the driver from a variety of sources which includes genomics data, sensors, wearable devices to integrate data for deep analysis.<\/p>\n\n\n\n
Evolutionary Applications of RWE<\/strong><\/p>\n\n\n\n In this era of advancing technologies, digital data\ntechnologies are improving healthcare to overcome challenges. It is important\nto extract efficient value from healthcare data and tackle the data to bring\nout innovative solutions. Following points will focus on innovative digital\ntechnologies to optimize RWE generation:<\/p>\n\n\n\n RWE compares treatments and dosage easily, helping\nhealthcare providers select the best combination of treatment for patients. The\ncomparison helps in cutting costs and provides insights into adverse effects\nand best cure.<\/p>\n\n\n\n In some cases, drugs fail to deliver the predicted\nefficiency because of failure on part of the patients to adhere to the\nrequirements of the treatment. Such data can help companies set up educational\nprograms based on segmentation data. Moreover, it can also help companies\nunderstand if any drug is ineffective and if further innovations may be needed\nto boost performance. This is known as Patient Adherence Study.<\/strong><\/p>\n\n\n\n Payers in the sector constantly face the issue of increased healthcare cost. To make sure their budget is spent effectively, they ask for evidence. Pharma companies can make use of RWE to provide the required data and information and structure the right plan.<\/p>\n\n\n\n Food and Drug Administration (FDA) <\/strong>and other regulators around the\nworld are realizing the importance of real-world evidence, and using it to\nmonitor post-market safety of patients. Moreover, it includes the recording of\nadverse events which further helps them make regulatory decisions.<\/p>\n\n\n\n Future Industrial Perspective<\/strong><\/p>\n\n\n\n Pharma companies strive to innovate, create and\ndeliver the right treatments at the right time to the right patients at the\nright cost. RWE is widely foreseen to be one of the instruments towards\nachieving this. By interlinking healthcare providers, payers, patients, and\nother relevant stakeholders, RWE is likely to become central for establishing\neffective healthcare frameworks in the future.<\/p>\n\n\n\n Changing the Treatment Protocol<\/strong><\/p>\n\n\n\n Beyond the potential regulatory benefits, RWE can be\nused today to enhance decisions about what to prescribe for particular patient\ncohorts. Various companies are already providing clinical decision support that\ngathers RWE on treatment outcomes along with genomics data to allow clinicians\nto assess outcomes by the patient cluster. Networks of clinicians also report\nthe outcomes of treatments they have prescribed, ensuring that the data is\nconstantly updated.<\/p>\n\n\n\n RWE is also of relevance to the payers, who have this\ndata through the claims they receive. But there is growing pressure from payers\nto gather more outcomes-based RWE to help them determine what they should\ncontinue to pay for. Within the broader healthcare ecosystem, the emphasis is\nmainly on breaking down the inefficiencies and information processes between\nthe different payers.<\/p>\n\n\n\n The goal is to streamline the process in order to\nsupport value-based care and develop new pharmaceutical and medical devices to\nimprove outcomes and reduce costs. But for this to happen, healthcare\norganizations must achieve more efficient data integration to realize a true\nand complete view of patients and their data.<\/p>\n\n\n\n All-in-all RWE is transforming through advancements of technology to enable more accurate and structured treatment to patients.<\/p>\n\n\n\n